Entity Common Stock, Shares Outstanding of Editas Medicine, Inc. from 06 May 2016 to 27 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Editas Medicine, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 06 May 2016 to 27 Feb 2026.
  • Editas Medicine, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 27 Feb 2026 was 97,871,999, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Editas Medicine, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 97,871,999 +14,895,715 +18% 27 Feb 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 97,618,660 +15,070,561 +18% 31 Oct 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 89,920,164 +7,443,728 +9% 07 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 82,976,284 +738,310 +0.9% 28 Feb 2025 10-K 05 Mar 2025 2024 FY
Q3 2024 82,548,099 +874,411 +1.1% 30 Oct 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 82,476,436 +843,817 +1% 02 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 82,237,974 +13,242,368 +19% 03 May 2024 10-Q 08 May 2024 2024 Q1
Q3 2023 81,673,688 +12,910,728 +19% 27 Oct 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 81,632,619 +12,895,369 +19% 28 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 68,995,606 +354,490 +0.52% 28 Apr 2023 10-Q 05 May 2023 2023 Q1
Q3 2022 68,762,960 +364,420 +0.53% 28 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 68,737,250 +475,995 +0.7% 29 Jul 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 68,641,116 +814,680 +1.2% 29 Apr 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 68,518,971 +1,156,180 +1.7% 14 Feb 2022 10-K 24 Feb 2022 2021 FY
Q3 2021 68,398,540 +6,064,322 +9.7% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 68,261,255 +5,991,349 +9.6% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 67,826,436 +12,829,888 +23% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 67,362,791 +12,487,399 +23% 14 Feb 2021 10-K 26 Feb 2021 2020 FY
Q3 2020 62,334,218 +11,031,333 +22% 30 Oct 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 62,269,906 +12,754,578 +26% 31 Jul 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 54,996,548 +5,773,562 +12% 01 May 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 54,875,392 +5,783,141 +12% 14 Feb 2020 10-K 26 Feb 2020 2019 FY
Q3 2019 51,302,885 +3,492,695 +7.3% 01 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 49,515,328 +1,839,684 +3.9% 01 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 49,222,986 +2,018,610 +4.3% 03 May 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 49,092,251 08 Feb 2019 10-K 01 Mar 2019 2018 FY
Q3 2018 47,810,190 +5,690,579 +14% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 47,675,644 +6,048,198 +15% 03 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 47,204,376 +5,855,928 +14% 27 Apr 2018 10-Q 04 May 2018 2018 Q1
Q3 2017 42,119,611 +5,463,675 +15% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 41,627,446 +5,013,365 +14% 07 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 41,348,448 +4,740,312 +13% 05 May 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 36,679,926 01 Feb 2017 10-K 03 Mar 2017 2016 FY
Q3 2016 36,655,936 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 36,614,081 01 Aug 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 36,608,136 06 May 2016 10-Q 13 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.